Parivash Nourjah

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi request reprint Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States
    Parivash Nourjah
    Office of Drug Safety, Division of Drug Risk Evaluation, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Pharmacoepidemiol Drug Saf 15:398-405. 2006
  2. ncbi request reprint Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program
    Allen Brinker
    Food and Drug Administration, Center for Drug Evaluation and Research, Office of Drug Safety, Rockville, MD 20857, USA
    Arch Dermatol 141:563-9. 2005
  3. ncbi request reprint Sex and age differences in serum potassium in the United States
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Clin Chem 49:190-2. 2003
  4. ncbi request reprint Troglitazone-induced liver failure: a case study
    David J Graham
    Office of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane, HFD 400, Room 15B 32, Rockville, MD 20857, USA
    Am J Med 114:299-306. 2003
  5. ncbi request reprint Patient characteristics associated with outpatient prescriptions for nabumetone and oxaprozin versus celecoxib and rofecoxib
    Allen Brinker
    Division of Drug Risk Evaluation, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, USA
    Am J Health Syst Pharm 62:739-43. 2005
  6. ncbi request reprint Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, White Oak, Bldg 22, Room 3424, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Arch Intern Med 167:1414-9. 2007
  7. doi request reprint Emergency department visits attributed to selected analgesics, United States, 2004-2005
    Mary Willy
    Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA
    Pharmacoepidemiol Drug Saf 18:188-95. 2009
  8. ncbi request reprint Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey
    Stephen R Benoit
    Food and Drug Administration, Rockville, Maryland, USA
    Eur J Cardiovasc Prev Rehabil 12:363-8. 2005
  9. doi request reprint Drug-risk communication to pharmacists: assessing the impact of risk-minimization strategies on the practice of pharmacy
    Lauren Y Lee
    Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
    J Am Pharm Assoc (2003) 48:494-500. 2008
  10. ncbi request reprint Factors associated with celecoxib and rofecoxib utilization
    Nigel S B Rawson
    Center for Health Care Policy and Evaluation, Eden Prairie, MN Oakville, ON, Canada
    Ann Pharmacother 39:597-602. 2005

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States
    Parivash Nourjah
    Office of Drug Safety, Division of Drug Risk Evaluation, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Pharmacoepidemiol Drug Saf 15:398-405. 2006
    ..To estimate the number of acetaminophen-associated overdoses in the United States and identify possible risk factors for intervention...
  2. ncbi request reprint Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program
    Allen Brinker
    Food and Drug Administration, Center for Drug Evaluation and Research, Office of Drug Safety, Rockville, MD 20857, USA
    Arch Dermatol 141:563-9. 2005
    ....
  3. ncbi request reprint Sex and age differences in serum potassium in the United States
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Clin Chem 49:190-2. 2003
  4. ncbi request reprint Troglitazone-induced liver failure: a case study
    David J Graham
    Office of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane, HFD 400, Room 15B 32, Rockville, MD 20857, USA
    Am J Med 114:299-306. 2003
    ..We evaluated the clinical features of all cases reported to the Food and Drug Administration and estimated the duration and magnitude of the risk of liver failure associated with continued use of the drug...
  5. ncbi request reprint Patient characteristics associated with outpatient prescriptions for nabumetone and oxaprozin versus celecoxib and rofecoxib
    Allen Brinker
    Division of Drug Risk Evaluation, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, USA
    Am J Health Syst Pharm 62:739-43. 2005
  6. ncbi request reprint Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, White Oak, Bldg 22, Room 3424, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Arch Intern Med 167:1414-9. 2007
    ..Warfarin sodium is widely used and causes bleeding; a review might suggest the need for regulatory action by the US Food and Drug Administration (FDA)...
  7. doi request reprint Emergency department visits attributed to selected analgesics, United States, 2004-2005
    Mary Willy
    Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA
    Pharmacoepidemiol Drug Saf 18:188-95. 2009
    ..To estimate the rate of emergency department (ED) visits attributed to selected analgesic-containing medications...
  8. ncbi request reprint Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey
    Stephen R Benoit
    Food and Drug Administration, Rockville, Maryland, USA
    Eur J Cardiovasc Prev Rehabil 12:363-8. 2005
    ..Although research exists on the relationship between QT prolongation and clinical outcome, few studies have described risk factors for prolonged QT interval in the general population...
  9. doi request reprint Drug-risk communication to pharmacists: assessing the impact of risk-minimization strategies on the practice of pharmacy
    Lauren Y Lee
    Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
    J Am Pharm Assoc (2003) 48:494-500. 2008
    ..To gain insight on the knowledge, opinions, barriers, and practices of pharmacists regarding drug risk-minimization tools...
  10. ncbi request reprint Factors associated with celecoxib and rofecoxib utilization
    Nigel S B Rawson
    Center for Health Care Policy and Evaluation, Eden Prairie, MN Oakville, ON, Canada
    Ann Pharmacother 39:597-602. 2005
    ..However, adverse reaction data suggest that the use of COX-2 selective NSAIDs is associated with clinically significant GI events...
  11. ncbi request reprint Topiramate-associated secondary angle-closure glaucoma: a case series
    Lopa Thambi
    Rockville, MD, USA
    Arch Ophthalmol 120:1108. 2002
  12. ncbi request reprint Trends in the use of ipecac in the ED setting: data from the 1992-2002 NHAMCS-ED (letter)
    Allen D Brinker
    Am J Emerg Med 24:759-61. 2006
  13. pmc Analyzing prescription drugs as causes of death on death certificates
    Diane K Wysowski
    Public Health Rep 119:520. 2004